A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide

Barbara Gamberi, Christian Berthou, Miguel Hernandez, Gianpietro Semenzato, Eleni Tholouli, Roman Hájek, Jo Caers, Meletios Dimopoulos, Monique C. Minnema, Bjorn Andreasson, Joana Parreira, Gerard Crotty, Kari Remes, Elisabeth Kueenburg, Barbara Rosettani, Antonia Di Micco, Sarah Peters, Pamela Bacon, Igor Wolfgang Blau

Open source

DOI: 10.1016/j.clml.2020.05.006
Published: 2020-10
Container: Clinical Lymphoma Myeloma and Leukemia
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.clml.2020.05.006,
  title = {A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide},
  author = {Barbara Gamberi and Christian Berthou and Miguel Hernandez and Gianpietro Semenzato and Eleni Tholouli and Roman Hájek and Jo Caers and Meletios Dimopoulos and Monique C. Minnema and Bjorn Andreasson and Joana Parreira and Gerard Crotty and Kari Remes and Elisabeth Kueenburg and Barbara Rosettani and Antonia Di Micco and Sarah Peters and Pamela Bacon and Igor Wolfgang Blau},
  year = {2020},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  doi = {10.1016/j.clml.2020.05.006},
  url = {https://doi.org/10.1016/j.clml.2020.05.006}
}

RIS

TY  - JOUR
TI  - A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide
AU  - Barbara Gamberi
AU  - Christian Berthou
AU  - Miguel Hernandez
AU  - Gianpietro Semenzato
AU  - Eleni Tholouli
AU  - Roman Hájek
AU  - Jo Caers
AU  - Meletios Dimopoulos
AU  - Monique C. Minnema
AU  - Bjorn Andreasson
AU  - Joana Parreira
AU  - Gerard Crotty
AU  - Kari Remes
AU  - Elisabeth Kueenburg
AU  - Barbara Rosettani
AU  - Antonia Di Micco
AU  - Sarah Peters
AU  - Pamela Bacon
AU  - Igor Wolfgang Blau
PY  - 2020
JO  - Clinical Lymphoma Myeloma and Leukemia
DO  - 10.1016/j.clml.2020.05.006
UR  - https://doi.org/10.1016/j.clml.2020.05.006
ER  -

APA

Gamberi, B., Berthou, C., Hernandez, M., Semenzato, G., Tholouli, E., Hájek, R., Caers, J., Dimopoulos, M., Minnema, M. C., Andreasson, B., Parreira, J., Crotty, G., Remes, K., Kueenburg, E., Rosettani, B., Micco, A. D., Peters, S., Bacon, P., & Blau, I. W. (2020). A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2020.05.006

Source records

crossref · retrieved 2026-09-25T08:29:10.541Z